ATS (ATS) Citi's Global Industrial Tech and Mobility Conference 2025 summary

Business overview and market positioning

• Revenue has grown from CAD 1 billion to CAD 3 billion over eight years, with significant margin expansion and quadrupled market cap.

• Provides automation equipment and processes for regulated, high-consequence end markets such as Life Sciences, food safety, nuclear energy, and EV.

• Competitive advantages include global reach, proprietary technology, digital and AI capabilities, and a strong services arm.

Growth drivers and end markets

• Life Sciences represents about 50% of revenue, with strong growth in GLP-1 drugs, radiopharmaceuticals, diabetes devices, and pharmacy automation.

• Food safety and nuclear energy are growing, with automation solutions for primary/secondary processing and nuclear reactor refurbishment.

• EV market now represents 8-10% of revenue, with a harvest strategy and right-sized operations after recent headwinds.

Services, digital, and recurring revenue

• Shift from 80-90% integration to a more balanced mix: integration (40%), standard products (30%), and services/digital (30%).

• Services and digital offerings include predictive maintenance, Connected Care, and process improvements, aiming for recurring revenue to approach 40%.

• Higher-margin services drive customer retention and margin expansion.